US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Correvio Pharma Corp.

0.4199

0.0000

Volume:- -

Turnover:- -

Market Cap:27.79M

PE:-0.53

High:0.4199

Open:0.4199

Low:0.4199

Close:0.4199

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Correvio Pharma Corp.

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.correvio.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Correvio Pharma Corp., a specialty pharmaceutical company, engages in developing therapeutics worldwide. Its products comprise Aggrastat (tirofiban hydrochloride), (an intravenous anti-platelet drug for patients with acute coronary syndrome; and Brinavess (vernakalant IV), a novel, atrial-preferential antiarrhythmic agent for the rapid conversion of recent onset atrial fibrillation to sinus rhythm. The company also offers Trevyent, a development stage drug/device combination product for pulmonary arterial hypertension; Xydalba, a treatment for acute bacterial skin and skin structure infections; and Zevtera/Mabelio, a cephalosporin antibiotic for intravenous administration with rapid bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria. Correvio Pharma Corp. was incorporated in 2018 and is headquartered in Vancouver, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CORV/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CORV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORV\",,,,,undefined,":{"symbol":"CORV","market":"US","secType":"STK","nameCN":"Correvio Pharma Corp.","latestPrice":0.4199,"timestamp":1590523200000,"preClose":0.4199,"halted":3,"volume":0,"delay":0,"floatShares":65011067,"shares":66191487,"eps":-0.794655,"marketStatus":"Halted","change":0,"latestTime":"05-26 16:00:00 EDT","open":0.4199,"high":0.4199,"low":0.4199,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.794655,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1748505600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.4199,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORV\",,,,,undefined,":{"symbol":"CORV","floatShares":65011067,"roa":"-28.95%","roe":"-1158.13%","lyrEps":-0.794655,"shares":66191487,"dividePrice":0,"high":0.4199,"amplitude":0,"preClose":0.4199,"low":0.4199,"week52Low":0.21,"pbRate":"18.07","week52High":2.79,"institutionHeld":0.1341,"latestPrice":0.4199,"eps":-0.794655,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.794655,"open":0.4199,"prevYearClose":0.41},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.correvio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0029},{"period":"1month","weight":0.0736},{"period":"3month","weight":-0.0057},{"period":"6month","weight":-0.0128},{"period":"1year","weight":0.1166},{"period":"ytd","weight":0.0087}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Correvio Pharma Corp., a specialty pharmaceutical company, engages in developing therapeutics worldwide. Its products comprise Aggrastat (tirofiban hydrochloride), (an intravenous anti-platelet drug for patients with acute coronary syndrome; and Brinavess (vernakalant IV), a novel, atrial-preferential antiarrhythmic agent for the rapid conversion of recent onset atrial fibrillation to sinus rhythm. The company also offers Trevyent, a development stage drug/device combination product for pulmonary arterial hypertension; Xydalba, a treatment for acute bacterial skin and skin structure infections; and Zevtera/Mabelio, a cephalosporin antibiotic for intravenous administration with rapid bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria. Correvio Pharma Corp. was incorporated in 2018 and is headquartered in Vancouver, Canada.","exchange":"NASDAQ","name":"Correvio Pharma Corp.","nameEN":"Correvio Pharma Corp."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CORV\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CORV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-03-30","symbol":"CORV","fiscalQuarterEnding":"2019/12","expectedEps":-0.13,"name":null,"time":"","type":"earning","dateTimestamp":1585540800000,"reportTimeType":"","actualEps":-0.1},{"date":"2019-11-14","symbol":"CORV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.17,"defaultRemindTime":1573722000000,"name":null,"time":"Pre-Market","dateTimestamp":1573707600000,"actualEps":-0.2},{"date":"2019-08-14","symbol":"CORV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.21,"defaultRemindTime":1565769600000,"name":null,"time":"Pre-Market","dateTimestamp":1565755200000,"actualEps":-0.37},{"market":"US","date":"2019-05-08","symbol":"CORV","fiscalQuarterEnding":"2019/03","expectedEps":-0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1557288000000,"reportTimeType":"pre","actualEps":-0.23},{"market":"US","date":"2019-03-13","symbol":"CORV","fiscalQuarterEnding":"2018/12","expectedEps":-0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1552449600000,"reportTimeType":"pre","actualEps":-0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CORV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CORV\",market:\"US\",delay:false,,,undefined,":{}}}